Malignant pleural mesothelioma (MPM) is an aggressive disease with a severe prognosis. Medical treatment for MPM unresectable patients is still unsatisfactory; therefore novel therapeutic approaches are urgently needed. Immunotherapy represents a promising treatment for MPM patients. Here, we'll discuss the most promising immunotherapeutic treatments currently under active investigation for this still dreadful disease.
Calabro, L., Rossi, G., Maio, M. (2018). New horizons from immunotherapy in malignant pleural mesothelioma. JOURNAL OF THORACIC DISEASE, 10(Suppl. 2), S322-S332 [10.21037/jtd.2017.12.88].
New horizons from immunotherapy in malignant pleural mesothelioma
Rossi G.;Maio M.
2018-01-01
Abstract
Malignant pleural mesothelioma (MPM) is an aggressive disease with a severe prognosis. Medical treatment for MPM unresectable patients is still unsatisfactory; therefore novel therapeutic approaches are urgently needed. Immunotherapy represents a promising treatment for MPM patients. Here, we'll discuss the most promising immunotherapeutic treatments currently under active investigation for this still dreadful disease.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
New-horizons-from-immunotherapy-2018.pdf
non disponibili
Tipologia:
PDF editoriale
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
273.85 kB
Formato
Adobe PDF
|
273.85 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
Utilizza questo identificativo per citare o creare un link a questo documento:
https://hdl.handle.net/11365/1083808